Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data

Flores Gerrit Weverling; Mieke W H Roeven; Klaartje Kasper Nijssen; Annoek E C Broers; Elisabeth Dovern; Anna van Rhenen; Geerte van Sluis; Carin Hazenberg; Peter van Balen; Maria T Kuipers; Karen M K de Vooght; Linde M Morsink; Jürgen Kuball; Erfan Nur; Moniek Dewitte

doi:10.1182/bloodadvances.2023011190

Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data

Flores Gerrit Weverling, Mieke W H Roeven, Klaartje Kasper Nijssen, Annoek E C Broers, Elisabeth Dovern, Anna van Rhenen, Geerte van Sluis, Carin Hazenberg, Peter van Balen, Maria T Kuipers, Karen M K de Vooght, Linde M Morsink, Jürgen Kuball, Erfan Nur, Moniek Dewitte^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

28 Downloads (Pure)

Original language	English
Pages (from-to)	1683-1686
Number of pages	4
Journal	Blood Advances
Volume	8
Issue number	7
Early online date	17 Jan 2024
DOIs	https://doi.org/10.1182/bloodadvances.2023011190
Publication status	Published - 9 Apr 2024

Access to Document

10.1182/bloodadvances.2023011190Licence: CC BY-NC-ND

blooda_adv-2023-011190-mainFinal published version, 429 KBLicence: CC BY-NC-ND

Cite this

Weverling, F. G., Roeven, M. W. H., Nijssen, K. K., Broers, A. E. C., Dovern, E., van Rhenen, A., Sluis, G. V., Hazenberg, C., van Balen, P., Kuipers, M. T., de Vooght, K. M. K., Morsink, L. M., Kuball, J., Nur, E., & Dewitte, M. (2024). Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data. Blood Advances, 8(7), 1683-1686. https://doi.org/10.1182/bloodadvances.2023011190

@article{6fde6413e7504a5c9ce0c9b1e05203bb,

title = "Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data",

author = "Weverling, {Flores Gerrit} and Roeven, {Mieke W H} and Nijssen, {Klaartje Kasper} and Broers, {Annoek E C} and Elisabeth Dovern and {van Rhenen}, Anna and Sluis, {Geerte van} and Carin Hazenberg and {van Balen}, Peter and Kuipers, {Maria T} and {de Vooght}, {Karen M K} and Morsink, {Linde M} and J{\"u}rgen Kuball and Erfan Nur and Moniek Dewitte",

year = "2024",

month = apr,

day = "9",

doi = "10.1182/bloodadvances.2023011190",

language = "English",

volume = "8",

pages = "1683--1686",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "The American Society of Hematology",

number = "7",

}

Weverling, FG, Roeven, MWH, Nijssen, KK, Broers, AEC, Dovern, E, van Rhenen, A, Sluis, GV, Hazenberg, C, van Balen, P, Kuipers, MT, de Vooght, KMK, Morsink, LM, Kuball, J, Nur, E & Dewitte, M 2024, 'Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data', Blood Advances, vol. 8, no. 7, pp. 1683-1686. https://doi.org/10.1182/bloodadvances.2023011190

TY - JOUR

T1 - Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation

T2 - Dutch real-world data

AU - Weverling, Flores Gerrit

AU - Roeven, Mieke W H

AU - Nijssen, Klaartje Kasper

AU - Broers, Annoek E C

AU - Dovern, Elisabeth

AU - van Rhenen, Anna

AU - Sluis, Geerte van

AU - Hazenberg, Carin

AU - van Balen, Peter

AU - Kuipers, Maria T

AU - de Vooght, Karen M K

AU - Morsink, Linde M

AU - Kuball, Jürgen

AU - Nur, Erfan

AU - Dewitte, Moniek

PY - 2024/4/9

Y1 - 2024/4/9

UR - http://www.scopus.com/inward/record.url?scp=85190163050&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2023011190

DO - 10.1182/bloodadvances.2023011190

M3 - Letter

C2 - 38231018

SN - 2473-9529

VL - 8

SP - 1683

EP - 1686

JO - Blood Advances

JF - Blood Advances

IS - 7

ER -

Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data

Access to Document

Other files and links

Cite this